Association of corticosteroid (CS) exposure with treatment failure in patients (pts) with advanced melanoma treated with immune checkpoint inhibitors (ICIs)

被引：0
|
作者：
Le, H. M. L. [1 ]
Pozas Perez, J. [2 ]
San Roman Gil, M. V. [2 ]
Serrano Domingo, J. J. [2 ]
Larkin, J. [1 ]
机构：
[1] NHS Fdn Trust, Med Dept, Royal Marsden Hosp, London, England
[2] Ramon y Cajal Univ Hosp, Med Oncol Dept, Madrid, Spain
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2292
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1158P
引用
收藏
页码：S691 / S691
页数：1
相关论文
共 50 条
  • [31] Development and Validation of a Prognostic Risk Model for Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors
    Stukalin, Igor
    Navani, Vishal
    Gupta, Mehul
    Ruan, Yibing
    Boyne, Devon J.
    O'Sullivan, Dylan E.
    Meyers, Daniel E.
    Goutam, Siddhartha
    Sander, Michael
    Ewanchuk, Benjamin W.
    Brenner, Darren R.
    Suo, Aleksi
    Cheung, Winson Y.
    Heng, Daniel Y. C.
    Monzon, Jose G.
    Cheng, Tina
    ONCOLOGIST, 2023, 28 (09): : 812 - 822
  • [32] Enhanced dacarbazine efficacy in advanced melanoma patients previously treated with immune checkpoint inhibitors in Korea
    Lee, Soo Jung
    Na, Jihyun
    Lee, In Hee
    Lee, Jeeyeon
    Lee, Seok-Jong
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [33] Baseline neutrophil-to-lymphocyte ratio in patients with advanced melanoma treated with immune checkpoint inhibitors
    Machet, L.
    Zaragoza, J.
    Finon, A.
    Garnier, M.
    Maillard, H.
    Caille, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (01) : 224 - 224
  • [34] Healthcare resource utilization (HCRU) and costs in patients (pts) with advanced cancer treated with immune checkpoint inhibitors (ICIs) who experienced select immune-related adverse events (irAEs)
    George, S.
    Zheng, Y.
    Bell, E. J.
    Engel-Nitz, N. M.
    White, J. C.
    Lal, L. S.
    Kim, R.
    Krulewicz, S.
    Smith, J.
    Liu, F. X.
    ANNALS OF ONCOLOGY, 2020, 31 : S968 - S969
  • [35] Association of time to second-line (2L) immune-checkpoint inhibitors (ICI) and outcomes with ICIs in patients (pts) with advanced urothelial carcinoma (aUC).
    Makrakis, Dimitrios
    Talukder, Rafee
    Dawsey, Scott
    Carril, Lucia
    Stewart, Tyler F.
    Morales-Barrera, Rafael
    Park, Joseph J.
    Fulgenzi, Claudia Angela Maria
    Murgic, Jure
    Vather-Wu, Naomi
    de Kouchkovsky, Ivan
    Devitt, Michael Edward
    Di Lorenzo, Giuseppe
    Gupta, Kavita
    Tripathi, Nishita
    Zakopoulou, Roubini
    Tripathi, Abhishek
    Lu, Eric
    Grivas, Petros
    Khaki, Ali Raza
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [36] Clinical characteristics and treatment efficacy of immune checkpoint inhibitors (ICIs) in patients with ICIs-induced Adrenal insufficiency
    Xiang, Jing
    Liu, Xueni
    Hao, Yue
    Zhu, Yanyan
    Wu, Minhua
    Lou, Jian
    Wang, Yonghui
    Xu, Chunwei
    Xie, Yanru
    Huang, Jianhui
    TRANSLATIONAL ONCOLOGY, 2023, 38
  • [37] Treatment beyond progression with immune checkpoint inhibitors in advanced melanoma.
    Sobczuk, Pawel
    Czarnecka, Anna Malgorzata
    Spalek, Mateusz
    Teterycz, Pawel
    Dudzisz-Sledz, Monika
    Switaj, Tomasz
    Rogala, Pawel
    Placzke, Joanna
    Kozak, Katarzyna
    Borkowska, Aneta
    Kosela-Paterczyk, Hanna
    Rutkowski, Piotr
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [38] Clinical outcome differences based on gender in patients with advanced renal cell carcinoma (aRCC) treated with immune checkpoint inhibitors (ICIs)
    Choi, Yujin
    Goswamy, Rohit Vivek
    Wei, Mengting
    Liu, Yuan
    Yildirim, Ahmet
    Brown, Jacqueline T.
    Nazha, Bassel
    Martini, Dylan J.
    Hartman, Caitlin
    McClintock, Greta Russler
    Zhuang, Tony
    Kissick, Haydn
    Harris, Wayne B.
    Carthon, Bradley Curtis
    Kucuk, Omer
    Master, Viraj A.
    Bilen, Mehmet Asim
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [39] Safety and efficacy of immune checkpoint inhibitors (ICIs) in patients (pts) with cardiac metastases (mets) from solid tumors
    Nassar, Amin
    Abou Alaiwi, Sarah
    El Zarif, Talal
    Denu, Ryan Austin
    Hayek, Salim S.
    Goodman, Rachel S.
    Woodford, Rachel
    Neilan, Tomas G.
    Haykal, Tarek
    Kojima, Yuji
    Trevino, Alexandra
    Hui, Gavin
    Tandon, Ankita
    El-Am, Edward
    Mittra, Arjun
    Baena, Javier
    Choudhary, Arrush
    Grynberg, Shirly
    Choueiri, Toni K.
    Naqash, Abdul Rafeh
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [40] Non-invasive biomarkers for response and survival prediction in patients with advanced solid tumours treated with immune checkpoint inhibitors (ICIs)
    Bernatowicz, K.
    Vieito, M.
    Berche, R.
    Alonso, G.
    Galvao, V.
    Oberoi, H. K.
    Brana, I.
    Saavedra, O.
    Munoz-Couselo, E.
    Grussu, F.
    Belen, A.
    Serna, G.
    Rotxes, M.
    Sanz, M.
    Tabernero, J.
    Toledo, R.
    Nuciforo, P.
    Garralda, E.
    Perez-Lopez, R.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S70 - S70
12345